NO930595D0 - Opploeselige salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)-pyrimidin-5-karboksylsyre-(n-metyl-n-(3-trifluormetyl-fenyl)-amid), fremgangsmaate for fremstilling derav, utgangsprod. og forbindelsenes anv. som legemiddel - Google Patents

Opploeselige salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)-pyrimidin-5-karboksylsyre-(n-metyl-n-(3-trifluormetyl-fenyl)-amid), fremgangsmaate for fremstilling derav, utgangsprod. og forbindelsenes anv. som legemiddel

Info

Publication number
NO930595D0
NO930595D0 NO930595A NO930595A NO930595D0 NO 930595 D0 NO930595 D0 NO 930595D0 NO 930595 A NO930595 A NO 930595A NO 930595 A NO930595 A NO 930595A NO 930595 D0 NO930595 D0 NO 930595D0
Authority
NO
Norway
Prior art keywords
amide
dimethyl
phenyl
amino
methyl
Prior art date
Application number
NO930595A
Other languages
English (en)
Other versions
NO930595L (no
NO300892B1 (no
Inventor
Klaus Dieter Kampe
Ernold Granzer
Michael Leineweber
Manfred Huettinger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO930595D0 publication Critical patent/NO930595D0/no
Publication of NO930595L publication Critical patent/NO930595L/no
Publication of NO300892B1 publication Critical patent/NO300892B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO930595A 1992-02-22 1993-02-19 Opplöselige salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)-pyrimidin-5-karboksylsyre-£N-metyl-N-(3-trifluormetyl-fenyl)-amid|, utgangsprodukter og forbindelsenes anvendelse som legemiddel NO300892B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4205483 1992-02-22

Publications (3)

Publication Number Publication Date
NO930595D0 true NO930595D0 (no) 1993-02-19
NO930595L NO930595L (no) 1993-08-23
NO300892B1 NO300892B1 (no) 1997-08-11

Family

ID=6452363

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930595A NO300892B1 (no) 1992-02-22 1993-02-19 Opplöselige salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)-pyrimidin-5-karboksylsyre-£N-metyl-N-(3-trifluormetyl-fenyl)-amid|, utgangsprodukter og forbindelsenes anvendelse som legemiddel

Country Status (16)

Country Link
US (1) US5795899A (no)
EP (1) EP0557877B1 (no)
JP (1) JP3258744B2 (no)
AT (1) ATE158581T1 (no)
AU (2) AU658265B2 (no)
CA (1) CA2089956A1 (no)
DE (1) DE59307402D1 (no)
DK (1) DK0557877T3 (no)
ES (1) ES2109382T3 (no)
FI (1) FI105097B (no)
GR (1) GR3025235T3 (no)
HU (1) HU210621B (no)
IL (1) IL104792A (no)
NO (1) NO300892B1 (no)
NZ (2) NZ264767A (no)
ZA (1) ZA931183B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE147384T1 (de) * 1992-02-22 1997-01-15 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE19625089A1 (de) * 1996-06-24 1998-01-02 Hoechst Ag 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19625088A1 (de) * 1996-06-24 1998-01-02 Hoechst Ag 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE60025243T2 (de) * 1999-10-12 2006-06-22 Takeda Pharmaceutical Co. Ltd. Pyrimidin-5-carboximidverbindungen, verfahren zur herstellung derselben und deren verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853220A1 (de) * 1978-12-09 1980-07-03 Hoechst Ag Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE3522940A1 (de) * 1985-06-27 1987-01-08 Hoechst Ag 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidin-5-carbonsaeure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln
ATE147384T1 (de) * 1992-02-22 1997-01-15 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Also Published As

Publication number Publication date
DE59307402D1 (de) 1997-10-30
IL104792A (en) 1997-09-30
JP3258744B2 (ja) 2002-02-18
CA2089956A1 (en) 1993-08-23
FI930718A (fi) 1993-08-23
FI105097B (fi) 2000-06-15
NZ264767A (en) 1995-10-26
ATE158581T1 (de) 1997-10-15
AU658265B2 (en) 1995-04-06
HU9300459D0 (en) 1993-05-28
ES2109382T3 (es) 1998-01-16
AU669463B2 (en) 1996-06-06
AU1136595A (en) 1995-04-13
ZA931183B (en) 1993-09-16
DK0557877T3 (da) 1998-04-27
HU210621B (en) 1995-06-28
NZ245937A (en) 1994-12-22
EP0557877B1 (de) 1997-09-24
NO930595L (no) 1993-08-23
FI930718A0 (fi) 1993-02-18
NO300892B1 (no) 1997-08-11
EP0557877A1 (de) 1993-09-01
JPH06184137A (ja) 1994-07-05
HUT63410A (en) 1993-08-30
AU3376093A (en) 1993-08-26
GR3025235T3 (en) 1998-02-27
IL104792A0 (en) 1993-06-10
US5795899A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
HUT48196A (en) Process for producing benzocycloheptene derivatives and pharmaceuticals comprising such active ingredient
ZA884919B (en) 3-demethylmevalonic acid derivatives,a process for their preparation,pharmaceutical products based on these compounds,their use and intermediates
ATE79538T1 (de) Dispergierbare zubereitung.
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
NO930596D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmaate for fremstilling derav, legemidler som inneholder forbindelsene og anvendelse derav
HUT45521A (en) Process for producing quinolinecarboxylic acid derivatives
NO930595L (no) Opploeselige salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)-pyrimidin-5-karboksylsyre-(n-metyl-n-(3-trifluormetyl-fenyl)-amid), fremgangsmaate for fremstilling derav, utgangsprod. og forbindelsenes anv. som legemiddel
ATE17350T1 (de) Salicylsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung.
ES2091509T3 (es) Procedimiento para la obtencion de derivados de isopreno.
EP0421102A3 (en) Substituted acrylic acid esters
PH24258A (en) Substituted quinoxyalyl-imidazolidine-2,4-diones,their use as medicaments and pharmaceutical preparation
IL86637A0 (en) (2-cyano-2-oximinoacetyl)-amino acid derivatives,their preparation and their use as pesticides
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
IN170286B (no)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2003